RLS Global AB (publ) RLS.ST Stock
0.45 SEK
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
35.7M SEK
LOW - HIGH [24H]
0.45
-
0.45 SEK
VOLUME [24H]
7.21K SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-0.4 SEK
RLS Global AB (publ) Price Chart
RLS Global AB (publ) RLS.ST Financial and Trading Overview
| RLS Global AB (publ) stock price | 0.45 SEK |
| Previous Close | 1 SEK |
| Open | 1.05 SEK |
| Bid | 1.02 SEK x 0 |
| Ask | 1.07 SEK x 0 |
| Day's Range | 1.05 - 1.09 SEK |
| 52 Week Range | 0.97 - 5.42 SEK |
| Volume | 18.81K SEK |
| Avg. Volume | 40.36K SEK |
| Market Cap | 86.66M SEK |
| Beta (5Y Monthly) | 0.634099 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8 SEK |
RLS.ST Valuation Measures
| Enterprise Value | 69.62M SEK |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 88.2526 |
| Price/Book (mrq) | 3.5342019 |
| Enterprise Value/Revenue | 70.898 |
| Enterprise Value/EBITDA | -2.802 |
Trading Information
RLS Global AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.634099 |
| 52-Week Change | -71.18% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.42 SEK |
| 52 Week Low | 0.97 SEK |
| 50-Day Moving Average | 1.72 SEK |
| 200-Day Moving Average | 2.65 SEK |
RLS.ST Share Statistics
| Avg. Volume (3 month) | 40.36K SEK |
| Avg. Daily Volume (10-Days) | 43.91K SEK |
| Shares Outstanding | 79.87M |
| Float | 52.13M |
| Short Ratio | N/A |
| % Held by Insiders | 47.87% |
| % Held by Institutions | 7.13% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2699.28% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -67.78% |
| Return on Equity (ttm) | -136.062% |
Income Statement
| Revenue (ttm) | 982K SEK |
| Revenue Per Share (ttm) | 0.01 SEK |
| Quarterly Revenue Growth (yoy) | -70.79% |
| Gross Profit (ttm) | -23250000 SEK |
| EBITDA | -24845000 SEK |
| Net Income Avi to Common (ttm) | -26716000 SEK |
| Diluted EPS (ttm) | -0.35 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 13.45M SEK |
| Total Cash Per Share (mrq) | 0.17 SEK |
| Total Debt (mrq) | 0 SEK |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.982 |
| Book Value Per Share (mrq) | 0.307 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -23923000 SEK |
| Levered Free Cash Flow (ttm) | -17802500 SEK |
Profile of RLS Global AB (publ)
| Country | Sweden |
| State | N/A |
| City | Mölndal |
| Address | Neongatan 5 |
| ZIP | 431 53 |
| Phone | 46 3 17 80 68 20 |
| Website | https://rls.global |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 9 |
RLS Global AB (publ), a medical technology company, develops and sells products for the treatment of illnesses in wound and oral care in Sweden. Its products include ChloraSolv that is used for the treatment of chronic diabetic foot and leg ulcers for diabetic patients; and CariSolv, a gel used for removing caries. The company was founded in 1996 and is based in Mölndal, Sweden.
Q&A For RLS Global AB (publ) Stock
What is a current RLS.ST stock price?
RLS Global AB (publ) RLS.ST stock price today per share is 0.45 SEK.
How to purchase RLS Global AB (publ) stock?
You can buy RLS.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for RLS Global AB (publ)?
The stock symbol or ticker of RLS Global AB (publ) is RLS.ST.
Which industry does the RLS Global AB (publ) company belong to?
The RLS Global AB (publ) industry is Drug Manufacturers-Specialty & Generic.
How many shares does RLS Global AB (publ) have in circulation?
The max supply of RLS Global AB (publ) shares is 80.05M.
What is RLS Global AB (publ) Price to Earnings Ratio (PE Ratio)?
RLS Global AB (publ) PE Ratio is now.
What was RLS Global AB (publ) earnings per share over the trailing 12 months (TTM)?
RLS Global AB (publ) EPS is -0.4 SEK over the trailing 12 months.
Which sector does the RLS Global AB (publ) company belong to?
The RLS Global AB (publ) sector is Healthcare.
RLS Global AB (publ) RLS.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| First North Sweden EUR PI FNSEEURPI | 1479.5 EUR 1617.29 USD |
-0.77
|
— — | — — | — — | — - | — — |
| First North Health Care PI FN20PI | 912.9 EUR 997.92 USD |
-1.17
|
— — | — — | — — | — - | — — |
| First North All-Share SEK FIRSTNORTHSEK | 123.34 SEK 12.04 USD |
-0.14
|
— — | — — | — — | — - | — — |
| First North All-Share DKK FIRSTNORTHDKK | 97.96 DKK 14.36 USD |
-0.62
|
— — | — — | — — | — - | — — |
| First North Sweden SEK GI FNSESEKGI | 1956.89 SEK 191.02 USD |
-0.28
|
— — | — — | — — | — - | — — |
| First North Sweden EUR GI FNSEEURGI | 1570.14 EUR 1716.38 USD |
-0.77
|
— — | — — | — — | — - | — — |
| First North Health Care GI FN20GI | 917.04 EUR 1002.44 USD |
-1.17
|
— — | — — | — — | — - | — — |
| First North All-Share EUR FIRSTNORTHEUR | 97.9 EUR 107.01 USD |
-0.64
|
— — | — — | — — | — - | — — |
| First North Sweden SEK PI FNSESEKPI | 1843.91 SEK 179.99 USD |
-0.28
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}